David E. Krantz, MD, PhD

Psychiatry University of California, Los Angeles, Los Angeles, CA 
Drosophila, Neurotransmitter transporters
"david e krantz"
Mean distance: 14.94 (cluster 11)


Sign in to add trainee
Rafael Romero grad student 2007 UCLA
Anna Grygoruk grad student 2009 UCLA
Elizabeth S. Brooks grad student 2011 UCLA
Audrey Chen grad student 2012 UCLA
Ciara A. Martin grad student 2009-2014 UCLA
Hakeem O. Lawal post-doc UCLA & CalTech
Christine N. Serway post-doc Univ. of New Mexico (FlyTree)


Sign in to add collaborator
Mark A. Frye collaborator
Sufia Sadaf collaborator 2016- UCLA
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mirman AM, Corlier J, Wilson AC, et al. (2022) Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder. Depression and Anxiety
Lee JC, Corlier J, Wilson AC, et al. (2021) Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder. Brain Stimulation. 14: 1015-1021
Lee JC, Wilson AC, Corlier J, et al. (2020) Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder. Journal of Affective Disorders. 277: 964-969
Sampson MM, Myers Gschweng KM, Hardcastle BJ, et al. (2020) Serotonergic modulation of visual neurons in Drosophila melanogaster. Plos Genetics. 16: e1009003
Harrigan J, Brambila DF, Meera P, et al. (2020) The environmental toxicant ziram enhances neurotransmitter release and increases neuronal excitability via the EAG family of potassium channels. Neurobiology of Disease. 143: 104977
Deshpande S, Freyberg Z, Lawal HO, et al. (2020) Vesicular neurotransmitter transporters in Drosophila melanogaster. Biochimica Et Biophysica Acta. Biomembranes. 183308
Cook IA, Congdon E, Krantz DE, et al. (2019) Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. Frontiers in Genetics. 10: 870
Levitt JG, Kalender G, O’Neill J, et al. (2019) Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy Journal of Psychiatry & Neuroscience : Jpn. 44: 1-9
Corlier J, Wilson A, Hunter AM, et al. (2019) Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cerebral Cortex (New York, N.Y. : 1991)
Hunter AM, Minzenberg MJ, Cook IA, et al. (2019) Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain and Behavior. e01275
See more...